Telatraz Adverse Reactions

Summary of the safety profile: Serious adverse drug reactions include anaphylactic reaction and angioedema which may occur rarely, and acute renal failure.
The incidence of adverse reactions was not dose related and showed no correlation with gender, age or race of the patients. The safety profile of telmisartan in patients treated for the reduction of cardiovascular morbidity was consistent with that obtained in hypertensive patients.
Tabulated list of adverse reactions: Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. (See table.)

Click on icon to see table/diagram/image

Description of Selected Adverse Reactions: Sepsis: An increased incidence of sepsis was observed with telmisartan. The event may be a chance finding or related to a mechanism currently not known (see Pharmacology: Pharmacodynamics under Actions).
Hypotension: This adverse reaction was reported as common in patients with controlled blood pressure who were treated with telmisartan for the reduction of cardiovascular morbidity on top of standard care.
Abnormal hepatic function/liver disorder: Most cases of hepatic function abnormal / liver disorder from post-marketing experience occurred in Japanese patients. Japanese patients are more likely to experience these adverse reactions.
Interstitial lung disease: Cases of interstitial lung disease have been reported from post-marketing experience in temporal association with the intake of telmisartan. However, a causal relationship has not been established.